219 related articles for article (PubMed ID: 18693591)
1. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
Saif I; Halim A; Altaf A; Saif M; Khalid M; Ahmad D; Imran H
J Ayub Med Coll Abbottabad; 2007; 19(4):26-8. PubMed ID: 18693591
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
[TBL] [Abstract][Full Text] [Related]
3. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
[TBL] [Abstract][Full Text] [Related]
4. Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Pflanz S; Henderson IS; McElduff N; Jones MC
Nephrol Dial Transplant; 1994; 9(8):1121-4. PubMed ID: 7800211
[TBL] [Abstract][Full Text] [Related]
5. [A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis].
Borrego J; Pérez del Barrio P; Serrano P; García Cortés MJ; Sánchez Perales MC; Borrego FJ; Liébana A; Gil Cunquero JM; Pérez Bañasco V
Nefrologia; 2000; 20(4):348-54. PubMed ID: 11039260
[TBL] [Abstract][Full Text] [Related]
6. Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
d'Almeida Filho EJ; da Cruz EA; Hoette M; Ruzany F; Keen LN; Lugon JR
Sao Paulo Med J; 2000 Nov; 118(6):179-84. PubMed ID: 11120549
[TBL] [Abstract][Full Text] [Related]
7. Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Toida T; Fukudome K; Fujimoto S; Yamada K; Sato Y; Chiyotanda S; Kitamura K
Clin Nephrol; 2012 Sep; 78(3):216-23. PubMed ID: 22874110
[TBL] [Abstract][Full Text] [Related]
8. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
[TBL] [Abstract][Full Text] [Related]
9. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
10. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Evenepoel P; Selgas R; Caputo F; Foggensteiner L; Heaf JG; Ortiz A; Kelly A; Chasan-Taber S; Duggal A; Fan S
Nephrol Dial Transplant; 2009 Jan; 24(1):278-85. PubMed ID: 18820280
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients.
Hess B; Binswanger U
Nephrol Dial Transplant; 1990; 5(8):630-2. PubMed ID: 23276001
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
de Francisco AL; Leidig M; Covic AC; Ketteler M; Benedyk-Lorens E; Mircescu GM; Scholz C; Ponce P; Passlick-Deetjen J
Nephrol Dial Transplant; 2010 Nov; 25(11):3707-17. PubMed ID: 20530499
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
[TBL] [Abstract][Full Text] [Related]
15. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
[TBL] [Abstract][Full Text] [Related]
16. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
Hutchison AJ; Maes B; Vanwalleghem J; Asmus G; Mohamed E; Schmieder R; Backs W; Jamar R; Vosskühler A
Nephron Clin Pract; 2006; 102(2):c61-71. PubMed ID: 16224198
[TBL] [Abstract][Full Text] [Related]
18. The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: a comparative study.
Schaefer K; Scheer J; Asmus G; Umlauf E; Hagemann J; von Herrath D
Nephrol Dial Transplant; 1991; 6(3):170-5. PubMed ID: 1866045
[TBL] [Abstract][Full Text] [Related]
19. The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Assimon MM; Mousa S; Shaker O; Pai AB
Consult Pharm; 2010 Jan; 25(1):41-54. PubMed ID: 20211816
[TBL] [Abstract][Full Text] [Related]
20. Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
Ouellet G; Cardinal H; Mailhot M; Ste-Marie LG; Roy L
Ther Apher Dial; 2010 Apr; 14(2):172-7. PubMed ID: 20438539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]